Glitazones & Dementia; Diabetes Insipidus Name Change? Islet Transplant Success – Medpage Today

by Kristen Monaco, Staff Writer, MedPage Today October 18, 2022
A study of U.S. veterans with type 2 diabetes found that those treated with thiazolidinedione had a 22% reduced risk of all-cause dementia versus metformin, while those treated with a sulfonylurea saw a 12% higher risk. (BMJ Open Diabetes Research & Care)
Front-of-package warnings about high-added sugar content helped deter 15.6% of parents from buying such beverages. (JAMA Network Open)
One consensus group proposed changing the name of diabetes insipidus to “arginine vasopressin deficiency (AVP-D)” for central etiologies and “arginine vasopressin resistance (AVP-R)” for nephrogenic etiologies. (Endocrine Connections)
The magnitude of the link between diabetes and cardiovascular events weakened in recent years, likely due to the “modern, multifactorial approaches to diabetes,” researchers reported in a JAMA research letter.
A total of 74% of patients with type 1 diabetes who underwent an islet transplantation — either alone or after kidney transplantation — achieved insulin independence, with half maintaining this for up to 8 years. (Diabetes Care)
Metformin use was linked with half the odds of developing atrial fibrillation compared with other standard diabetes treatments. (Cell Reports Medicine)
Is it time we rethink using BMI as the sole threshold for prescribing obesity treatments? (KHN)
Eli Lilly is suing to block Dr. Reddy’s Laboratories from making a generic version of teriparatide (Forteo), an injectable drug for osteoporosis. (Bloomberg Law)
Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2022 MedPage Today, LLC. All rights reserved.
Medpage Today is among the federally registered trademarks of MedPage Today, LLC and may not be used by third parties without explicit permission.

source